Refine by
Oasmia Drug Designations Equipment & Supplies
1 equipment items found
Manufactured by:Vivesto AB based inSolna, SWEDEN
Apealea is approved by the European regulatory authority EMA for use in combination with carboplatin for the treatment of adult patients with first relapse of platinum-sensitive epithelial ovarian cancer, primary peritoneal cancer and fallopian tube cancer. Apealea has also received orphan drug designation from the US regulatory authority FDA for the treatment of ...